Cdc25 Created 2026-10-14 Updated 2026-10-14
Cdc25 is a protein phosphatase: it removes inhibitory phosphate groups from CDK1, relieving inhibition of an appropriately prepared cyclin B–CDK1 assembly. Its reaction is removal, whereas Wee1 is a protein kinase adding inhibitory modification. Removing the inhibitory sites is different from removing the activating phosphorylation supplied by CAK.[ref]
Cdc25 action on CDK1 must also be distinguished from phosphorylation of Cdc25 itself. In cell-cycle activation feedback, CDK1-dependent regulation promotes Cdc25 activity, which can then activate additional inhibited CDK1. The complete regulatory path can involve intermediates. A histone H1 kinase assay of a mixture reports downstream protein kinase action; assigning its change to Cdc25 requires a perturbation or an independent protein phosphatase assay, rather than interpreting histone H1 labeling as phosphate removal.
Cell-cycle activation feedback is the reinforcement of Cdc2 activation through Cdc25 and suppression of Wee1. Its role is to help make transitions in the cell cycle decisive; the cell-cycle hysteresis experiment tests the resulting states rather than inferring them solely from circuit arrows.
Cyclin-dependent kinase 1 Created 2026-10-14 Updated 2026-10-14
Cyclin-dependent kinase 1, abbreviated CDK1 and historically called Cdc2, is the catalytic protein kinase in the CDK1–cyclin B assembly. CDK1 transfers a phosphate group from ATP to a protein substrate; cyclin B supplies a regulatory binding partner. Binding and phosphorylation regulate catalytic competence, so detecting CDK1 protein alone does not establish activity. The distinction makes a durable catalytic component reusable as the cell cycle changes its regulatory inputs.[ref]
The cell-cycle activation feedback uses CDK1 activity as both an output and a regulatory input: activity promotes Cdc25 activation and suppresses Wee1, reinforcing release from inhibitory phosphorylation. The already described cell-cycle hysteresis experiment tests how that output depends on history at matched cyclin B input; the histone H1 kinase assay below explains what its output measures. A binding diagram alone cannot establish hysteresis.
Positive feedback 2026-10-13
Positive feedback closes a causal loop whose net effect reinforces an initiating change. A loop with two inhibitory links can therefore have positive feedback. In signal transduction, a product that increases the activity of the enzyme making it illustrates reinforcement; the consequences depend on the full mathematical model, not just the loop sign. See signaling feedback.
A biological example is cell-cycle activation feedback. Cyclin B binds Cdc2, whose activity promotes activation of Cdc25; Cdc25 removes inhibitory phosphorylation from Cdc2, permitting further activation. Cdc2 also inhibits Wee1, an enzyme that inhibits Cdc2 through phosphorylation. That second return contains two inhibitions and therefore also has positive feedback. These are regulatory paths, not a claim that every connection is a single direct molecular encounter. [ref]
Reinforcement can preserve a decision after its initiating stimulus weakens: returning from the high state may require a lower input than entering it. The cell-cycle hysteresis experiment below tests this history dependence at matched cyclin B concentrations. A steep response alone is insufficient evidence of bistability, and finite observation times can make slow relaxation look like memory. A proposed switch must specify its input, readout and observation interval.
Figure 1.
A synthetic positive feedback switch and its hysteresis thresholds
. Original computed equilibrium points of a normalized saturating mathematical model, not cyclin B measurements or a fit to Cdc2. Filled intersections are asymptotically stable; the open intersection is unstable. With , a slow sweep follows stable branches until their folds; with , the same positive return has only one stable equilibrium point. Details.
Wee1 Created 2026-10-14 Updated 2026-10-14
Wee1 is a protein kinase that inhibits CDK1 by adding a phosphate group at an inhibitory site. Purified human Wee1 phosphorylated Cdc2 at Tyr15 in the reported in vitro assay, with no Thr14 modification detected. A catalytic-site mutation abolished both the measured protein kinase activity and the ability to inhibit division. This identifies a catalytic brake rather than merely a correlated protein amount.[ref]
Do not attribute all inhibitory CDK1 phosphorylation to Wee1: the Xenopus laevis Myt1 experiment separately identified activity toward both Thr14 and Tyr15. Nor does every phosphorylation inhibit its target: activating Thr161 modification in the studied Xenopus laevis Cdc2 has the opposite role. In cell-cycle activation feedback, suppression of Wee1 removes a brake on CDK1, reinforcing the transition without implying that the total amount of either protein instantly disappears.